(R)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 1g

Methyl 3-Methylpyridine-2-carboxylate>98.0%(GC)5g

2-Bromo-4-hydroxy-5-methoxybenzaldehyde, 95.0%, 1g

methyl 2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-1,3-benzodiazole-4-carboxylate, 95%, 250mg

4-Hydroxy-2-nitrobenzaldehyde, 95.0%, 1g

TERT-BUTYL 3-THIOXOPIPERAZINE-1-CARBOXYLATE, 95.0%, 5g

3-Amino-3-(4-fluorophenyl)propan-1-ol, 98%, 5g

4-Fluoro-3-(trifluoromethyl)benzonitrile>98.0%(GC)25g

Myristic acid, min. 98%, for biochemistry, 500 g, plastic packaging.

5-Fluoro-4-methoxy-2-nitroaniline, 95.0%, 1g

1,5-Dimethyl-1H-imidazole-4-carboxylic acid, 95.0%, 5g

trans-tert-Butyl (4-fluoropiperidin-3-yl)carbamate, 95.0%, 500mg

4-[2-(4-Fluoro-phenyl)-ethyl]-piperidine hydrochloride, 500mg